The Department of Agriculture (DA) is embarking on a P1-billion
biotechnology program that will tap Philippine indigenous plant
species for value-added processing into pharmaceutical, cosmetic,
and food products.
Agriculture Secretary Domingo F. Panganiban said DA is mapping
out an integrated biotechnology program.
"We're working on a program that will use indigenous
materials for pharmaceuticals, condiments, or other uses
so that DA will have an integral operation in biotechnology," Panganiban
said in an interview.
Alicia G. Ilaga, DA biotechnology program director, said
DA's proposal is still set for approval and for funding under
the General Appropriations Act approved DA budget.
"We already have a roadmap, but it has yet to be approved.
The target is to supply the world market with products that
use natural ingredients. We're playing a jigsaw puzzle here-putting
small pieces together so that we'll have a biotech industry
that will enable us to export to the world market," Ilaga
said in a separate interview.
Records show that there is a -billion market in Japan, US,
Korea, and Europe for herbal pharmaceutical ingredients or
products for which the Philippines can carve a niche for
itself.
The Philippines has vast biodiversity or natural resources
that can be rich source of innovative medicinal and food
products.
"In the Philippines, we have Banaba, Lagundi, Damong
Maria. We have indigenous materials that already have active
pharmaceutical ingredients while they in the US have yet
to genetically modify resources just to obtain those ingredients," she
said.
The biotechnology program proposes the use of an existing
DA-attached corporation such as the National Agribusiness
Corp. (NABCOR) or Philippine Genetics Inc. to run biotechnology
operations under which government will be sharing the risks
and the profits of biotechnology ventures.
However, over the long term, the aim is to entice the private
sector to risk capital and fund biotechnology research and
development (R&D).
"We're setting directions for research and development,
and then we'll get it incubated. It's really the private
sector which should support this industry. It's not the business
of government to be in business. In everything, we want to
bring projects to a point that there are private sector takers
to sustain it," she said.
To cut costs and maximize benefits, the biotechnology program
has proposed the use of existing laboratories and equipment
of the Bureau of Animal Industry and Bureau of Plant Industry.
These facilities will be established in a site that will
be open for private and public use.
Since a major problem of most technologies developed by
Filipinos is marketing, the program aims to find markets
for these technologies.
"If we can set up markets for these technologies, just
imagine how many thousands of hectares will benefit from
these?" she said.
For reforestation, instead of merely using forest species
such as gmelina, government can encourage reforesting using
banaba trees which can serve as source of corosolic acid,
a medicinal ingredient used to cure diabetes and which has
a huge market owing to nine million cases of diabetes in
the country. A biotechnology center will also have locations
for lease to the private sector. Revenue generation will
be shared between private users and the government.
The program has so far planned the development of local
pharmaceutical herbs like Banaba, Sambong, Lagundi for valueadded
processing and eventual export
It will also nurture the putting up of venture capitals
where investors can be convinced to finance technologies
that have high profitability and high marketability potentials
stemming from the technology's innovation or market dominance.
"An incubation facility and a venture capital fund
will leapfrog the biotechnology industry," she said.
The biotechnology center will also be a venue for pilot-testing
of new technologies.
"To commercialize a technology, we have to do it first
on laboratory scale and then pilot it in a small scale level
to test the market, to test the product," she said.